We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
ImmunityBio
IBRX
$8.1B
| $571K | ﹤0.01% |
112,604
+3,077
| +3% | +$16.9K |
|
2402
Dyne Therapeutics
DYN
$4.9B
| $570K | ﹤0.01% |
49,214
+396
| +0.8% | +$4.58K |
|
2403
Vital Farms
VITL
$525M
| $569K | ﹤0.01% |
38,159
+1,691
| +5% | +$23.3K |
|
2404
Atea Pharmaceuticals
AVIR
$420M
| $568K | ﹤0.01% |
118,093
+1,979
| +2% | +$10K |
|
|
CTO
2405
CTO Realty Growth
CTO
$815M
| $568K | ﹤0.01% |
31,055
+626
| +2% | +$12K |
|
2406
The Joint Corp
JYNT
$119M
| $568K | ﹤0.01% |
40,632
+2,199
| +6% | +$34K |
|
2407
Organogenesis Holdings
ORGO
$239M
| $567K | ﹤0.01% |
210,787
+16,099
| +8% | +$47K |
|
|
ORC
2408
Orchid Island Capital
ORC
$1.31B
| $566K | ﹤0.01% |
53,912
+358
| +0.7% | +$3.65K |
|
2409
Opendoor
OPEN
$3.38B
| $563K | ﹤0.01% |
501,684
+6,127
| +1% | +$11.7K |
|
2410
Accel Entertainment
ACEL
$987M
| $562K | ﹤0.01% |
72,971
+526
| +0.7% | +$4.52K |
|
|
SLGC
2411
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $562K | ﹤0.01% |
223,915
+4,513
| +2% | +$12.6K |
|
|
KZR
2412
DELISTED
Kezar Life Sciences
KZR
| $561K | ﹤0.01% |
7,973
+87
| +1% | +$6.45K |
|
2413
Xponential Fitness
XPOF
$211M
| $561K | ﹤0.01% |
24,466
+511
| +2% | +$10.5K |
|
2414
Oppenheimer Holdings
OPY
$1.2B
| $560K | ﹤0.01% |
13,223
-312
| -2% | -$11.5K |
|
2415
FRP Holdings
FRPH
$421M
| $559K | ﹤0.01% |
20,744
+60
| +0.3% | +$1.71K |
|
2416
Orrstown Financial Services
ORRF
$838M
| $559K | ﹤0.01% |
24,128
+8,502
| +54% | +$217K |
|
2417
Southern Missouri Bancorp
SMBC
$850M
| $559K | ﹤0.01% |
12,194
+7
| +0.1% | +$352 |
|
2418
Covenant Logistics
CVLG
$872M
| $555K | ﹤0.01% |
32,120
-2,030
| -6% | -$36.4K |
|
2419
Crescent Energy
CRGY
$3.82B
| $553K | ﹤0.01% |
46,082
+5,271
| +13% | +$72.5K |
|
2420
Peoples Financial Services
PFIS
$707M
| $553K | ﹤0.01% |
10,676
+169
| +2% | +$9K |
|
|
DM
2421
DELISTED
Desktop Metal, Inc.
DM
| $549K | ﹤0.01% |
40,371
-2,376
| -6% | -$49.5K |
|
2422
Lifestance Health
LFST
$4.14B
| $548K | ﹤0.01% |
110,982
+1,417
| +1% | +$8.76K |
|
2423
Sana Biotechnology
SANA
$980M
| $546K | ﹤0.01% |
138,332
+770
| +0.6% | +$3.77K |
|
2424
Destination XL Group
DXLG
$35.4M
| $545K | ﹤0.01% |
80,762
-285
| -0.4% | -$1.83K |
|
|
TSVT
2425
DELISTED
2seventy bio
TSVT
| $545K | ﹤0.01% |
58,160
+612
| +1% | +$8.63K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.